KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Payables (2020 - 2025)

Organon (OGN) has 6 years of Payables data on record, last reported at $952.0 million in Q4 2025.

  • For Q4 2025, Payables fell 17.43% year-over-year to $952.0 million; the TTM value through Dec 2025 reached $952.0 million, down 17.43%, while the annual FY2025 figure was $952.0 million, 17.43% down from the prior year.
  • Payables reached $952.0 million in Q4 2025 per OGN's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Payables topped out at $1.7 billion in Q3 2021 and bottomed at $952.0 million in Q4 2025.
  • Average Payables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
  • Peak YoY movement for Payables: soared 433.59% in 2021, then plummeted 38.55% in 2022.
  • A 5-year view of Payables shows it stood at $1.4 billion in 2021, then decreased by 18.09% to $1.1 billion in 2022, then rose by 16.08% to $1.3 billion in 2023, then dropped by 12.25% to $1.2 billion in 2024, then fell by 17.43% to $952.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $952.0 million in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.